1-1 of 1
Paola Paganoni
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First results from the Phase 1 study of APL-4098, an oral potent GCN2 inhibitor for the treatment of Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) and Myelodysplastic Syndromes (MDS)/AML

Free
Shaun Fleming, Shuhying Tan, Mridula Mokoonlall, Andrew McQuillan, Paul Yeh, Hun Chuah, Rueben Amofa, Laurie Green, Paola Paganoni, Misba Beerahee, Brian Hamilton, Nadine Clemo, Sanjay Aggarwal, Richard Dillon
Journal: Blood
Blood (2025) 146 (Supplement 1): 6945.
https://doi.org/10.1182/blood-2025-6945
Published: 2025